What are the costs of atrial fibrillation?
Open accessAbstract
The costs of atrial fibrillation (AF) are linked to the general cost of managing AF patients in different health-care systems, as well as the cost of managing AF-related complications (e.g. hospitalizations and long-term complications, such as stroke). In addition, indirect medical costs, such as care for patients who do not recuperate fully from a vascular event, and non-medical costs such as loss of work force add to the costs of AF. All estimations for cost of AF and cost of AF therapy are based on assumptions and markedly influenced by these cost determinants. This urges for extreme caution not to take cost estimates at their absolute values. In fact, even relative comparisons between interventions may have different consequences in terms of direct and indirect costs in different health-care settings. While newer therapeutic options appear to increase the cost of AF management, newer antithrombotic substances and adequate rhythm control therapy also carry the promise of preventing the two major drivers of AF-related cost, hospitalizations and AF-related complications. Formal assessment of the cost of AF requires adjustment to local practice, and more data are clearly needed especially from primary care to better estimate the 'real' cost impact of AF.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Atrial fibrillation is known to have a significant impact on health care costs, with the major cost-drivers being hospitalizations, stroke, and loss of productivity.
“AF is known to have a significant impact on health care costs, with the major cost-drivers being hospitalizations, stroke, and loss of productivity.6, 27, 28”
From Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study (2014) · cites this paper as [28]
Atrial fibrillation is known to have a significant impact on health care costs, with the major cost-drivers being hospitalizations, stroke, and loss of productivity.
“AF is known to have a significant impact on health care costs, with the major cost-drivers being hospitalizations, stroke, and loss of productivity.6, 27, 28”
From Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study (2014) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215 · see citing works
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205 · see citing works
Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,875 · see citing works
Self-citationImpact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575 · see citing works
Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Bailey, K. R., Abhayaratna, W. P., Seward, J. B., & Tsang, T. S. M. (2006) · Circulation · doi:10.1161/circulationaha.105.595140 · Cited by 2,564 · see citing works
Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial Fibrillation
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,066 · see citing works
Kannel, W. B., Wolf, P. A., Benjamin, E. J., & Levy, D. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00583-9 · Cited by 2,033 · see citing works
Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · EP Europace · doi:10.1093/europace/euq350 · Cited by 1,749 · see citing works
Self-citationStewart, S., Hart, C. L., Hole, D. J., & McMurray, J. J. V. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01236-6 · Cited by 1,562 · see citing works
Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation
Hohnloser, S. H., Crijns, H. J. G. M., van Eickels, M., Gaudin, C., Page, R. L., Torp-Pedersen, C. T., & Connolly, S. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803778 · Cited by 1,125 · see citing works
Lenient versus strict rate control in patients with atrial fibrillation
Van Gelder, I. C., Groenveld, H. F., Crijns, H. J. G. M., Tuininga, Y. S., Tijssen, J. G. P., Alings, A. M., Hillege, H. L., Bergsma-Kadijk, J. A., Cornel, J. H., Kamp, O., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001337 · Cited by 1,033 · see citing works
Increasing Prevalence of Atrial Fibrillation and Flutter in the United States
Naccarelli, G. V., Varker, H., Lin, J., & Schulman, K. L. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.07.022 · Cited by 868 · see citing works
Rosamond, W. D., Chambless, L. E., Folsom, A. R., Cooper, L. S., Conwill, D. E., Clegg, L. X., Wang, C.-H., & HEISS, G. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809243391301 · Cited by 827 · see citing works
Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK
Stewart, S., Murphy, N., Walker, A., McGuire, A., & McMurray, J. J. V. (2004) · Heart · doi:10.1136/hrt.2002.008748 · Cited by 590 · see citing works
Evidence of Improving Prognosis in Heart Failure
Macintyre, K., Capewell, S., Stewart, S., Chalmers, J. W. T., Boyd, J., Finlayson, A. R., Redpath, A., Pell, J. P., & McMurray, J. J. V. (2000) · Circulation · doi:10.1161/01.cir.102.10.1126 · Cited by 553 · see citing works
Acute Stroke With Atrial Fibrillation
Jørgensen, H. S., Nakayama, H., Reith, J., Raaschou, H. O., & Olsen, T. S. (1996) · Stroke · doi:10.1161/01.str.27.10.1765 · Cited by 526 · see citing works
Wattigney, W. A., Mensah, G. A., & Croft, J. B. (2003) · Circulation · doi:10.1161/01.cir.0000083722.42033.0a · Cited by 505 · see citing works
Secular trends in the prevalence of atrial fibrillation: The Framingham study
Wolf, P. A., Benhamin, E. J., Belanger, A. J., Kannel, W. B., Levy, D., & D'Agostino, R. B. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90288-4 · Cited by 446 · see citing works
Characteristics, Outcome, and Care of Stroke Associated With Atrial Fibrillation in Europe
Lamassa, M., Carlo, A. D., Pracucci, G., Basile, A. M., Trefoloni, G., Vanni, P., Spolveri, S., Baruffi, M. C., Landini, G., Ghetti, A., et al. (2001) · Stroke · doi:10.1161/01.str.32.2.392 · Cited by 433 · see citing works
Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation
Freeman, J. V., Zhu, R. P., Owens, D. K., Garber, A. M., Hutton, D. W., Go, A. S., Wang, P. J., & Turakhia, M. P. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-1-201101040-00289 · Cited by 427 · see citing works
Assessing the Direct Costs of Treating Nonvalvular Atrial Fibrillation in the United States
Coyne, K. S., Paramore, C., Grandy, S., Mercader, M. A., Reynolds, M. W., & ZIMETBAUM, P. J. (2006) · Value in Health · doi:10.1111/j.1524-4733.2006.00124.x · Cited by 422 · see citing works
Jahangir, A., Lee, V., Friedman, P. A., Trusty, J. M., Hodge, D. O., Kopecky, S. L., Packer, D. L., Hammill, S. C., Shen, W.-K., & Gersh, B. J. (2007) · Circulation · doi:10.1161/circulationaha.106.644484 · Cited by 392 · see citing works
Kirchhof, P. F., Auricchio, A., Bax, J. J., Crijns, H. J. G. M., Camm, A. J., Diener, H., Goette, A., Hindricks, G., Hohnloser, S., KAPPENBERGER, L. J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm358 · Cited by 381 · see citing works
Self-citationHughes, M., Lip, G. Y. H., & on behalf of the Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-08-0508 · Cited by 371 · see citing works
Self-citationSteger, C. M., Pratter, A., Martinek-Bregel, M., Avanzini, M. H., Valentin, A., Slaný, J., & Stöllberger, C. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.030 · Cited by 297 · see citing works
Rising Rates of Hospital Admissions for Atrial Fibrillation
Friberg, J., Buch, P., Scharling, H., Gadsbøll, N., & Jensen, G. B. (2003) · Epidemiology · doi:10.1097/01.ede.0000091649.26364.c0 · Cited by 284 · see citing works
Cost of care distribution in atrial fibrillation patients: the COCAF study
Heuzey, J. L., PAZIAUD, O., Piot, O., Saïd, M. A., Copie, X., Lavergne, T., & Guize, L. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00524-6 · Cited by 280 · see citing works
Atrial Fibrillation Is Associated with Severe Acute Ischemic Stroke
Dulli, D. A., Stanko, H., & Levine, R. L. (2003) · Neuroepidemiology · doi:10.1159/000068743 · Cited by 277 · see citing works
The Acute STroke Registry and Analysis of Lausanne (ASTRAL)
Michel, P., Odier, C., Rutgers, M. P., Reichhart, M. D., Maeder, P. P., Meuli, R. A., Wintermark, M., Maghraoui, A., Faouzi, M., Croquelois, A., et al. (2010) · Stroke · doi:10.1161/strokeaha.110.596189 · Cited by 237 · see citing works
Ringborg, A., Nieuwlaat, R., Lindgren, P., Jönsson, B., Fidan, D., Maggioni, A. P., Lopez-Sendon, J. L., Stepinska, J., Cokkinos, D. V., & Crijns, H. J. G. M. (2008) · EP Europace · doi:10.1093/europace/eun048 · Cited by 229 · see citing works
Lourenço, T., Armstrong, N., N’Dow, J., Nabi, G., Deverill, M., Pickard, R. S., Vale, L. D., MacLennan, G., Fraser, C. M., McClinton, S., et al. (2008) · Health Technology Assessment · doi:10.3310/hta12350 · Cited by 221 · see citing works
Kirchhof, P., Bax, J., Blomstrom-Lundquist, C., Calkins, H., Camm, A. J., Cappato, R., Cosio, F., Crijns, H., Diener, H.-C., Goette, A., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp235 · Cited by 202 · see citing works
Self-citationCharacteristics Associated With Physician Discipline
Kohatsu, N. D., Gould, D., Ross, L., & Fox, P. J. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.6.653 · Cited by 180 · see citing works
Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00018 · Cited by 173 · see citing works
Main, C., Moxham, T., Wyatt, J. C., Kay, J. D., Anderson, R., & Stein, K. (2010) · Health Technology Assessment · doi:10.3310/hta14480 · Cited by 166 · see citing works
Friberg, L., Hammar, N., Pettersson, H., & Rosenqvist, M. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm308 · Cited by 146 · see citing works
Current Perceptions of the Epidemiology of Atrial Fibrillation
Kannel, W. B., & Benjamin, E. J. (2008) · Cardiology Clinics · doi:10.1016/j.ccl.2008.09.015 · Cited by 138 · see citing works
The Impact of Atrial Fibrillation on the Cost of Stroke: The Berlin Acute Stroke Study
Brüggenjürgen, B., Rossnagel, K., Roll, S., Andersson, F. L., Selim, D., Müller-Nordhorn, J., Nolte, C. H., Jungehülsing, G. J., Villringer, A., & Willich, S. N. (2007) · Value in Health · doi:10.1111/j.1524-4733.2006.00160.x · Cited by 136 · see citing works
REYNOLDS, M. R., Essebag, V., ZIMETBAUM, P. J., & Cohen, D. J. (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.00819.x · Cited by 121 · see citing works
Pikto−Pietkiewicz, W. (2009) · PubMed · Cited by 113 · see citing works
GRANT, A. M., Wileman, S., Ramsay, C. R., Bojke, L., Epstein, D. M., Sculpher, M. J., Macran, S., Kilonzo, M. M., Vale, L. D., Francis, J., et al. (2008) · Health Technology Assessment · doi:10.3310/hta12310 · Cited by 112 · see citing works
Cost-Effectiveness of Rhythm versus Rate Control in Atrial Fibrillation
Marshall, D. A., Levy, A. R., Vidaillet, H. J., Jr., Fenwick, E. A. L., Slee, A. E., Blackhouse, G., Greene, H. L., Wyse, D. G., Nichol, G., OʼBrien, B. J., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-9-200411020-00005 · Cited by 112 · see citing works
McKenna, C., Palmer, S., Rodgers, M., Chambers, D., Hawkins, N., Golder, S., Hout, S. V., Pepper, C., TODD, D. M., & Woolacott, N. F. (2008) · Heart · doi:10.1136/hrt.2008.147165 · Cited by 81 · see citing works
Rodgers, M., McKenna, C., Palmer, S., Chambers, D., Hout, S. V., Golder, S., Pepper, C., TODD, D. M., & Woolacott, N. F. (2008) · Health Technology Assessment · doi:10.3310/hta12340 · Cited by 79 · see citing works
Cost-effectiveness of Therapies for Patients With Nonvalvular Atrial Fibrillation
Eckman, M. H., Falk, R. H., & Pauker, S. G. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.15.1669 · Cited by 74 · see citing works
ZIMETBAUM, P. J., Reynolds, M. R., Ho, K. K. L., Gaziano, T. A., McDonald, M. J., McClennen, S., Berezin, R. H., Josephson, M. E., & Cohen, D. J. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00821-x · Cited by 74 · see citing works
Kupersmith, J., Holmes-Rovner, M. M., Hogan, A. J., Rovner, D. R., & Gardiner, J. C. (1995) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(05)80017-9 · Cited by 73 · see citing works
Hagens, V., Vermeulen, K. M., TenVergert, E. M., VANVELDHUISEN, D., Bosker, H. A., Otto Kamp, B., Kingma, J. H., Tijssen, J. G. P., Crijns, H. J. G. M., & VanGelder, I. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.020 · Cited by 70 · see citing works
Cost-Effectiveness of Cardioversion and Antiarrhythmic Therapy in Nonvalvular Atrial Fibrillation
Catherwood, E., Fitzpatrick, W. D., Greenberg, M. L., Holzberger, P. T., Malenka, D. J., Gerling, B. R., & Birkmeyer, J. D. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-8-199904200-00002 · Cited by 65 · see citing works
Changing Trends of Hospital Utilization in Patients After Their First Episode of Atrial Fibrillation
Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Bailey, K. R., Seward, J. B., & Tsang, T. S. M. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.04.025 · Cited by 62 · see citing works
Atrial fibrillation: the cost of illness in Sweden
Ericson, L., Bergfeldt, L., & Björholt, I. (2010) · The European Journal of Health Economics · doi:10.1007/s10198-010-0261-3 · Cited by 62 · see citing works
The Costs of Care in Atrial Fibrillation and the Effect of Treatment Modalities in Germany
McBride, D., Mattenklotz, A. M., Willich, S. N., & Brüggenjürgen, B. (2008) · Value in Health · doi:10.1111/j.1524-4733.2008.00416.x · Cited by 59 · see citing works
Naccarelli, G. V., Johnston, S. S., Lin, J., Patel, P. P., & Schulman, K. L. (2010) · Clinical Cardiology · doi:10.1002/clc.20759 · Cited by 58 · see citing works
Time Trends in Long-term Survival After Stroke
Peltonen, M., Stegmayr, B., & Asplund, K. (1998) · Stroke · doi:10.1161/01.str.29.7.1358 · Cited by 56 · see citing works
Ghatnekar, O., & Glader, E. (2008) · Value in Health · doi:10.1111/j.1524-4733.2008.00359.x · Cited by 54 · see citing works
A Multinational Investigation of Time and Traveling Costs in Attending Anticoagulation Clinics
Jowett, S. M., Bryan, S., Mahé, I., Brieger, D. B., Carlsson, J., Kartman, B., & Nevinson, M. (2007) · Value in Health · doi:10.1111/j.1524-4733.2007.00253.x · Cited by 54 · see citing works
Holstenson, E., Ringborg, A., Lindgren, P., Coste, F., Diamand, F., Nieuwlaat, R., & Crijns, H. J. G. M. (2010) · EP Europace · doi:10.1093/europace/euq325 · Cited by 45 · see citing works
Waddington, C. S., Andrews, N. J., Höschler, K., et al. (2010) · Health Technology Assessment · doi:10.3310/hta14460-01 · Cited by 36 · see citing works
Kirchhof, P. F., Fetsch, T., Hanrath, P., Meinertz, T., Steinbeck, G., Lehmacher, W., & BREITHARDT, G. E. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.07.020 · Cited by 36 · see citing works
Self-citationSaborido, C. M., Hockenhull, J., Bagust, A., Boland, A., Dickson, R., & Todd, D. (2010) · Health Technology Assessment · doi:10.3310/hta14310 · Cited by 34 · see citing works
Can we improve outcomes in AF patients by early therapy?
Kirchhof, P. F. (2009) · BMC Medicine · doi:10.1186/1741-7015-7-72 · Cited by 26 · see citing works
Self-citationNeurally Mediated Syncope in 2 Patients With Extracardiac Disease
Vloka, M. E., Tamis, J. E., & Steinberg, J. S. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.6.625 · Cited by 21 · see citing works
Fenwick, E. A. L., Marshall, D. A., Blackhouse, G., et al. (2007) · Value in Health · doi:10.1111/j.1524-4733.2007.00254.x · Cited by 15 · see citing works
New concepts for old drugs to maintain sinus rhythm in patients with atrial fibrillation
Kirchhof, P. F., & BREITHARDT, G. E. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.01.023 · Cited by 12 · see citing works
Self-citationPrevalence and risk factors of atrial fibrillation in preterminal inpatients aged 60 years and over
Yang, J., Liu, B., Liu, D., Luo, Y., & Fang, F. A. N. G. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200810020-00019 · Cited by 7 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study
Chugh, S. S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E. J., Gillum, R. F., Kim, Y.-H., McAnulty, J. H., Zheng, Z.-J., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005119 · Cited by 4,506 · see citing works
- Authors
- Blomstrom Lundqvist, C., Lip, G. Y. H., & Kirchhof, P.
- Affiliations
- Birmingham City Hospital (GB)
- University Hospital Münster (DE)
- Corresponding author
- Kirchhof, P.
- Venue
- Europace
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-04-25
- Volume
- 13
- Issue
- suppl 2
- Pages
- ii9-ii12
- ISSN
- 1099-5129 (ISSN-L)
- 1532-2092
- OpenAlex
- W2104487774
- Cited by
- 42
- References
- 65
- Citations by year
- 2025: 4 · 2024: 2 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 5 · 2019: 1 · 2018: 3 · 2017: 5 · 2016: 2 · 2015: 4 · 2014: 2 · 2013: 3
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- EP Europace (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
- Keywords
- atrial fibrillation, economic burden, health care costs, hospital costs, stroke, antithrombotic therapy, rhythm control therapy, indirect costs, productivity loss, primary care, cost estimation
- MeSH terms
- Arrhythmias, Cardiac, Cost-Benefit Analysis, Delivery of Health Care, Europe, Hospitalization, Humans, Prevalence, Survival Rate, Survival Analysis, Health Care Costs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
